CIK 0002022416 · <br>Emerging growth company
Silexion Therapeutics Corp
Sign in to watch- Ticker
- SLXN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 972-8-6286005
- Business address
- 12 ABBA HILLEL ROAD, RAMAT GAN, Israel, 5250606
- Former names
- Biomotion Sciences
Securities
- SLXN Ordinary Shares Nasdaq
- SLXNW Warrant Nasdaq
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- DEF 14A Proxy Proxy Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Other events
- 10-K/A Report 10-K/A
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Unregistered share sale
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
Page 3 of 15 · 283 filings